Literature DB >> 4027886

Chemotherapy for inoperable infantile fibrosarcoma.

H E Grier, A R Perez-Atayde, H J Weinstein.   

Abstract

Infantile fibrosarcoma, an uncommon disease of childhood, generally occurs in an extremity and despite high local recurrence rates is usually curable with surgical excision alone. Two patients whose tumors were unresectable because of extensive retroperitoneal involvement are reported. Treatment with doxorubicin, vincristine, and cyclophosphamide resulted in complete clinical responses in both patients. They remain alive and tumor free 2.5 and 4 years from diagnosis. Chemotherapy as a single modality appears to be effective in controlling unresectable infantile fibrosarcoma.

Entities:  

Mesh:

Year:  1985        PMID: 4027886     DOI: 10.1002/1097-0142(19851001)56:7<1507::aid-cncr2820560705>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Orthopaedic case of the month: Rapidly progressive shoulder soft tissue mass in an 8-week-old girl.

Authors:  Nicole Marie Behnke; Moneil Patel; Tom Davidson; Alexandre Arkader
Journal:  Clin Orthop Relat Res       Date:  2010-12-03       Impact factor: 4.176

2.  Infantile fibrosarcoma: complete excision is the appropriate treatment.

Authors:  B R Cofer; P J Vescio; E S Wiener
Journal:  Ann Surg Oncol       Date:  1996-03       Impact factor: 5.344

3.  Clinical management of infantile fibrosarcoma: a retrospective single-institution review.

Authors:  Lalit Parida; Israel Fernandez-Pineda; John K Uffman; Andrew M Davidoff; Matthew J Krasin; Alberto Pappo; Bhaskar N Rao
Journal:  Pediatr Surg Int       Date:  2013-05-26       Impact factor: 1.827

4.  Margin status and multimodal therapy in infantile fibrosarcoma.

Authors:  Jason P Sulkowski; Mehul V Raval; Marybeth Browne
Journal:  Pediatr Surg Int       Date:  2013-06-14       Impact factor: 1.827

5.  Spontaneous regression of neonatal fibrosarcoma.

Authors:  N P Madden; R D Spicer; E B Allibone; I J Lewis
Journal:  Br J Cancer Suppl       Date:  1992-08

6.  Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.

Authors:  Alanna J Church; Monica L Calicchio; Valentina Nardi; Alena Skalova; Andre Pinto; Deborah A Dillon; Carmen R Gomez-Fernandez; Namitha Manoj; Josh D Haimes; Joshua A Stahl; Filemon S Dela Cruz; Sarah Tannenbaum-Dvir; Julia L Glade-Bender; Andrew L Kung; Steven G DuBois; Harry P Kozakewich; Katherine A Janeway; Antonio R Perez-Atayde; Marian H Harris
Journal:  Mod Pathol       Date:  2017-11-03       Impact factor: 7.842

7.  Infantile fibrosarcoma-like tumor driven by novel RBPMS-MET fusion consolidated with cabozantinib.

Authors:  Ajay Gupta; Jennifer A Belsky; Kathleen M Schieffer; Kristen Leraas; Elizabeth Varga; Sean D McGrath; Selene C Koo; Vincent Magrini; Richard K Wilson; Peter White; Elaine R Mardis; Kris R Jatana; Catherine E Cottrell; Bhuvana A Setty
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.